EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Predictors of immunotherapy response in gastric cancer: the role of the tumor microenvironment and integrative predictive models

Elisaveta Andreevna Tsarenkova, Anna Yuryevna Kalinchuk, Elena Olegovna Shmakova, Sergey Vladimirovich Vtorushin, Evgeniya Sergeevna Grigoryeva, Lyubov Aleksandrovna Tashireva

Clinical and Translational Oncology · 16.08.2026

DOI: 10.1007/s12094-026-04547-7 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical and Translational Oncology, online erschienen am 16.08.2026. Verfasst von Elisaveta Andreevna Tsarenkova und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Laboratory of Molecular Therapy of Cancer, Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk,…. Die Arbeit nennt 84 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunotherapy holds promise for gastric cancer, but its efficacy is constrained by primary and acquired resistance. Resistance mechanisms are complex, stemming from tumor features-such as the tumor microenvironment (TME). The TME is a dynamic ecosystem where tumor-immune-stromal interactions shape antitumor responses. Existing prognostic markers have clinical value, yet their insufficiency reflects the multidimensional nature of tumor-immune crosstalk. Emerging evidence indicates that immunotherapy response is a systems-level phenomenon. This review synthesizes current data on cellular, molecular, and systemic predictors, focusing on immune cell phenotypes, protein biomarkers, gene signatures, and metabolic factors. Integrative models capturing the functional state of the TME consistently outperform single biomarkers. Nevertheless, significant challenges remain, including a lack of standardization, limited prospective validation, and TME temporal plasticity, which complicates static biomarker assessments. Ultimately, predicting response requires understanding the tumor-immune ecosystem as an integrated, dynamic system to improve patient stratification and outcomes.

Schlagwörter

Stichwörter der Autor:innen

BiomarkersGastric cancerImmune checkpoint inhibitorsImmunotherapyTumor microenvironment

Autor:innen und Institutionen

  • The Laboratory of Molecular Therapy of Cancer, Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia. lisatsarenkova@mail.ru.
  • The Laboratory of Molecular Therapy of Cancer, Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia.
  • Laboratory of Translational Cellular and Molecular Biomedicine, National Research Tomsk State University, Tomsk, Russia.
  • The Department of General and Molecular Pathology, Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia.

Zitieren

APA

Tsarenkova, E. A., Kalinchuk, A. Y., Shmakova, E. O., Vtorushin, S. V., Grigoryeva, E. S., & Tashireva, L. A. (2026). Predictors of immunotherapy response in gastric cancer: the role of the tumor microenvironment and integrative predictive models. Clinical and Translational Oncology. https://doi.org/10.1007/s12094-026-04547-7

Vancouver

Tsarenkova EA, Kalinchuk AY, Shmakova EO, Vtorushin SV, Grigoryeva ES, Tashireva LA. Predictors of immunotherapy response in gastric cancer: the role of the tumor microenvironment and integrative predictive models. Clinical and Translational Oncology. 2026. doi:10.1007/s12094-026-04547-7

BibTeX
@article{Tsarenkova2026,
  author = {Tsarenkova, Elisaveta Andreevna and Kalinchuk, Anna Yuryevna and Shmakova, Elena Olegovna and Vtorushin, Sergey Vladimirovich and Grigoryeva, Evgeniya Sergeevna and Tashireva, Lyubov Aleksandrovna},
  title = {Predictors of immunotherapy response in gastric cancer: the role of the tumor microenvironment and integrative predictive models},
  journal = {Clinical and Translational Oncology},
  year = {2026},
  doi = {10.1007/s12094-026-04547-7}
}
Kostenlos starten →